Inquire Before Buying - Breast Cancer Treatment Market Size, Share & Trend by 2027

Global Breast Cancer Treatment Market Research Report: Forecast (2022-2027)

By Diagnosis (Blood Tests, Biopsy, Mammogram, Ultrasound, MRI), By Treatment (Surgery, Chemotherapy (Paclitaxel, Epirubicin, Docetaxel, Fluorouracil, Others (Doxorubicin, etc.)), T......argeted Therapy (Trastuzumab, Pertuzumab, Abemaciclib, Neratinib, Others (Palbociclib, etc.)), Others (Radiation Therapy, Hormone Therapy, etc.)), By End-User (Hospitals, Specialty Cancer Centers, Others (Ambulatory Surgery Centers, etc.)), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Country (The US, Canada, Mexico, Brazil, The UK, Germany, France, Italy, Spain, South Africa, GCC, China, Japan, India, Australia, South East Asia) Read more

Healthcare
Jun 2022
Pages 187
Report Format: PDF, Excel, PPT

Market Definition

Breast cancer occurs when breast cells begin to grow uncontrollably and create a mass of tissue known as a tumor. Similar to other cancers, it can expand into the tissues that surround the breast & also to other body parts while forming new tumors.

There are different forms of breast cancer, and each depends upon the area where the tumor is growing. As the disease is increasingly becoming common across different corners of the world, medical science is also developing rapidly and offering adequate and reliable diagnosis & treatment for the same.

Market Insights

The Global Breast Cancer Market is projected to grow at a CAGR of around 8.6% during the forecast period, i.e., 2022-27. The growth of the market would be driven primarily by the increasing prevalence of breast cancer worldwide, coupled with the dire need for adequate & efficient treatment for the same. Besides, the active participation of the leading players & the massive support of governments of different countries through investments in the research & development activities and favorable policies for clinical trials of drugs are other prominent aspects contributing to the market expansion globally.

Sanofi has been conducting various research & development initiatives to develop novel oral treatments for metastatic breast cancer.
AstraZeneca is actively working on developing therapeutics to treat estrogen receptor-positive breast cancer.

These trends, coupled with the introduction of advanced therapeutics by the leading biopharma companies, are set to boost the Global Breast Cancer Market through 2027. Furthermore, growing public awareness about breast cancer & its severity through various campaigns, advertisements, etc., is instigating cancer screening tests as a precautionary step and, in turn, projecting lucrative prospects for the global market over the forecast years.

Report Coverage	Details
Study Period	Historical Data: 2017-20
	Base Year: 2021
	Forecast Period: 2022-27
CAGR (2022-2027)	8.6%
Regions Covered	North America: The US, Canada, Mexico
	Europe: Germany, The UK, Germany, France, Italy, Spain, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, South East Asia, Rest of Asia-Pacific
	South America: Brazil, Rest of Latin America
	Middle East & Africa: South Africa, GCC, Rest of Middle East & Africa
Key Companies Profiled	AstraZeneca PLC, Bristol Myers Squibb, Eisai Co. Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Sanofi S.A., Others
Unit Denominations	USD Million/Billion

Market Segmentation

Based on Treatment:

Surgery
Chemotherapy
- Paclitaxel
- Epirubicin
- Docetaxel
- Fluorouracil
- Others (Doxorubicin, etc.)
Targeted Therapy
- Trastuzumab
- Pertuzumab
- Abemaciclib
- Neratinib
- Others (Palbociclib, etc.)
Others (Radiation Therapy, Hormone Therapy, etc.)

Here, targeted therapy acquired the largest share in the Global Breast Cancer Market in previous years, and the same trend is anticipated during 2022-27. It attributes primarily to its higher success rates than other treatments, i.e., leading to its greater preference as a treatment for breast cancer patients across both emerging & developed countries.

Introduction
1. Research Process
2. Assumption
3. Market Segmentation
4. Market Definition
Executive Summary
Global Breast Cancer Market Trends & Insights
Global Breast Cancer Market Regulation & Policy, By Country
Global Breast Cancer Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
Global Breast Cancer Market Hotspot and Opportunities
Global Breast Cancer Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
    1. Blood Tests
    2. Biopsy
    3. Mammogram
    4. Ultrasound
    5. MRI
  2. By Treatment
    1. Surgery
    2. Chemotherapy
      1. Paclitaxel
      2. Epirubicin
      3. Docetaxel
      4. Fluorouracil
      5. Others (Doxorubicin, etc.)
    3. Targeted Therapy
      1. Trastuzumab
      2. Pertuzumab
      3. Abemaciclib
      4. Neratinib
      5. Others (Palbociclib, etc.)
    4. Others (Radiation Therapy, Hormone Therapy, etc.)
  3. By End-User
    1. Hospitals
    2. Specialty Cancer Centers
    3. Others (Ambulatory Surgery Centers, etc.)
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  5. By Company
    1. Competition Characteristics
    2. Revenue Shares
    3. Competitor Placement in MarkNtel Advisor’s Quadrant
North America Breast Cancer Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. The US
    2. Canada
    3. Mexico
South America Breast Cancer Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. Brazil
    2. Rest of Latin America
Europe Breast Cancer Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
Middle East & Africa Breast Cancer Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. South Africa
    2. GCC
    3. Rest of Middle East & Africa
Asia-Pacific Breast Cancer Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. China
    2. Japan
    3. India
    4. Australia
    5. South East Asia
    6. Rest of Asia-Pacific
Global Breast Cancer Market Key Strategic Imperatives for Success and Growth
Competitive Outlook
1. Competition Matrix
  1. By Application Portfolio
  2. Brand Specialization
  3. Target Markets
  4. Target by Applications
  5. Research & Development
  6. Strategic Alliances
  7. Strategic Initiatives
2. Company Profiles (Business Description, By Application Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. AstraZeneca PLC
  2. Bristol Myers Squibb
  3. Eisai Co. Ltd.
  4. Eli Lilly and Company
  5. F. Hoffmann-La Roche AG
  6. Merck & Co., Inc.
  7. Novartis International AG
  8. Pfizer Inc.
  9. Sanofi S.A.
  10. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *

Contact Number *

Your Enquiry Details

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Related Reports

Talk to our Consultant

Customization Offered

Request Customization